Contraception
Conditions
Keywords
depo medroxyprogesterone acetate, Depo Provera, contraceptive compliance, pharmacists, Compliance in receiving additional Depo Provera injections, Satisfaction in receiving Depo Provera injections at a pharmacy compared with usual clinic
Brief summary
The purpose of this study is to see if it is a feasible arrangement to have women receive their second and third birth control injection (with Depo-Provera) at a pharmacy compared with receiving it a Planned Parenthood Clinic. Compliance with returning for injections as well as patient satisfaction with the method, providers, and location where injection was received will be assessed and compared between the two sites. The hypothesis is that there will be no difference in return rates for injections at either the pharmacy or the clinic site.
Detailed description
Women who want to use or are currently using Depo-Provera for contraception will be randomized to receive their next two injections either back at the Planned Parenthood clinic or at a local pharmacy where pharmacists are trained to give injections. After each injection, women will be asked to complete a questionnaire to assess their attitudes about the method of birth control, their providers, and the location where they received the injection.
Interventions
OTHERPharmacist-administered
women will receive their injections at a pharmacy by a clinical pharmacist
OTHERclinic-administered injections
women will return for their injections to the clinic where recruitment took place. They will receive one at 3 months and 6 months.
Sponsors
Pfizer
University of North Carolina, Chapel Hill
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* At least 18 y.o., English speaking/reading, presenting to Planned Parenthood to use Depo Provera (restarting, first use, or continuing use)
Exclusion criteria
* Under 18 years of age, English illiterate (reading and verbal)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compliance in returning for 3 month and 6 month injections | 3 months and 6 months after first injection |
Secondary
| Measure | Time frame |
|---|---|
| Attitudes about clinical setting | 3 months and 6 months |
Countries
United States
Outcome results
None listed